About Us
EyePen
InsuPadˇ
Investors
Contact Us
More
The EyePen is a diabetes management system intended for use by diabetic patients on insulin injection therapy. The system includes a smart add-on to insulin injection pens which tracks pen activity and transmits the data to a diabetes management app. Use of the system could enable users to improve their therapy adherence and compliance with no increased burden.
InsuPad is a non-invasive, simple, easy to use, medical device which enables patients on intensive insulin therapy to take control of their disease and reach treatment targets in more efficient way.
Read More >
Clinical studies have shown that InsuPad improves the medical outcome of current meal-time insulin therapy In the Barmer study: InsuPad reduces required prandial insulin dose by 28%, InsuPad achieves HbA1c goal similar to Standard of Care, InsuPad reduces hypoglycemia event rate by 46%,
Insuline Medical is a publicly-listed Israeli medical device company (INSL.TA), which has developed, and is manufacturing and marketing a device which enables patients on intensive insulin therapy to take control of their disease and reach treatment targets in a more effective and safer way.
